论文部分内容阅读
目的:观察依达拉奉治疗急性大面积脑梗死的疗效。方法:将60例急性脑梗死患者随机分为治疗组27例和对照组33例,均采用脱水降颅压、减轻脑水肿、抗血小板制剂、脑细胞保护剂(自由基清除剂除外)等常规治疗;治疗组在此基础上加用依达拉奉30mg静脉滴注,Bid。两组疗程均为10-14天,对比分析两组疗效。结果:治疗组临床疗效明显优于对照组。结论:依达拉奉治疗急性脑梗死疗效显著。
Objective: To observe the therapeutic effect of edaravone on acute large area cerebral infarction. Methods: Sixty patients with acute cerebral infarction were randomly divided into treatment group (n = 27) and control group (n = 33). All patients were treated with dehydration and intracranial pressure to relieve cerebral edema, antiplatelet agents, brain cell protection agents (except free radical scavengers) The treatment group was treated with Edaravone 30mg intravenously on the basis of this, Bid. Two groups of treatment are 10-14 days, comparative analysis of two groups. Results: The clinical efficacy of the treatment group was significantly better than that of the control group. Conclusion: Edaravone is effective in treating acute cerebral infarction.